Cardiff Oncology, Inc. (CRDF)

Last Closing Price: 1.88 (2026-03-06)

Net Income (Quarterly)

Net Income: Company's net profit or loss after all revenues, income items, and expenses have been accounted for. Because this figure is given after preferred dividend expense, it is the net income value allotted to common shareholders.

Cardiff Oncology, Inc. (CRDF) had Net Income of $-7.22M for the most recently reported fiscal quarter, ending 2025-12-31.

Figures for fiscal quarter ending 2025-12-31
Income Statement Financials
$0.24M
Net Income
$-7.22M
--
$0.24M
$8.07M
$-7.83M
$0.61M
$-7.22M
$-7.22M
$-7.22M
$-7.22M
$-7.22M
$-7.22M
$-7.83M
$-7.90M
66.84M
66.84M
$-0.11
$-0.11
Balance Sheet Financials
$60.13M
$0.58M
$1.76M
$61.88M
$16.39M
--
$0.10M
$16.50M
$45.39M
$45.39M
$45.39M
68.31M
Cash Flow Statement Financials
$-37.92M
$1.34M
$2.58M
$51.47M
$17.47M
$-34.00M
$5.69M
--
--
Fundamental Metrics & Ratios
3.67
--
--
--
--
100.00%
-3220.99%
-3220.99%
--
-2969.55%
-2972.43%
$-37.97M
--
--
--
0.00
--
1.34
67.41
-15.90%
-15.90%
-11.66%
-15.90%
$0.66
$-0.57
$-0.57